Monday, August 31, 2009

Biologics and RNA Drug Delivery LinkedIn Group Newsletter

Welcome to the August edition of the Biologics and RNA Drug Delivery LinkedIn Group Newsletter. This month, we’re looking at the latest news in the industry and preparing for the Biologics and RNA Drug Delivery Conference in Boston at the end of September! See the bottom of the newsletter for an exclusive discount for you, the LinkedIn Group members.

We have some exclusive video from last year’s Drug Delivery Partnerships event on the future of drug delivery in the pharmaceutical and biotech industry, and the importance of increased pipeline innovation.

Click here to watch it:

We invite you to participate in the following discussion question:

What needle-free biological delivery mechanism do you think holds the most promise for improved patient adherence?

We also have Twitter! Be sure to follow us for the latest news in drug delivery

There are industry breakthroughs in Biologic & RNA drug delivery every day- and we hope that you use this group to keep on top of them! Read on for some of the latest headlines in the drug delivery space:

Protein therapeutics worth $77bn by 2011, says RNCOS

Microneedle patch could boost compliance

New liquid protein tech could improve drug delivery

RXi presents RNA delivery data

Researchers target siRNA delivery

We’re gearing up for the Biologics & RNA Drug Delivery event, taking place September 23-25 in Boston, MA. As a member of this LinkedIn group, we’re offering you an exclusive discount of 20% off when you register for the event using the discount code XP1412LINK. To find out more about the conference, download the brochure here:


The Biologics Drug Formulation, Development & Delivery Professionals Team

Share this article with your social network, just click below to share now!

No comments :

Post a Comment